Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences

This document provides guidance on the study and analysis of sex differences in clinical trials of therapeutic products in order to generate evidence to advise on the optimal use of therapeutic products in both women and men.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2020-09-17

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data